Virology Follow up Study in Subjects Previously Treated With Telaprevir
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Study ID
- NCT00916474
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- telaprevir — DRUG
Study Details
Observational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time.
Key Dates
- First listed
- Jun 9, 2009
- Start date
- Jun 30, 2009
- Status verified
- Feb 2014
- Primary completion
- Dec 31, 2013
- Completion
- Dec 31, 2013
Study Design
- Enrollment
- 408 participants (actual)
Arms
- Arm: Cohort AObservational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time
- Arm: Cohort BObservational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time
Primary Outcome Measure
Proportion of subjects who maintain undetectable HCV RNA over time after achieving an SVR following telaprevir-based treatment [ Time Frame: 3 years ]
Locations (25)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alabama | Birmingham | Alabama | - | - |
| California | Coronado | California | - | - |
| California | Los Angeles | California | - | - |
| California | San Francisco | California | - | - |
| Colorado | Denver | Colorado | - | - |
| Colorado | Englewood | Colorado | - | - |
| Florida | Gainsville | Florida | - | - |
| Florida | Jacksonville | Florida | - | - |
| Florida | Miami | Florida | - | - |
| Georgia | Altanta | Georgia | - | - |
| Maryland | Baltimore | Maryland | - | - |
| Massachusetts | Boston | Massachusetts | - | - |
| Michigan | Novi | Michigan | - | - |
| Missouri | St Louis | Missouri | - | - |
| New Mexico | Albuquerque | New Mexico | - | - |
| New York | Manhasset | New York | - | - |
| New York | New York | New York | - | - |
| North Carolina | Chapel Hill | North Carolina | - | - |
| North Carolina | Durham | North Carolina | - | - |
| Ohio | Cincinnati | Ohio | - | - |
| South Carolina | Columbia | South Carolina | - | - |
| Texas | Houston | Texas | - | - |
| Texas | San Antonio | Texas | - | - |
| Virginia | Fairfax | Virginia | - | - |
| Virginia | Falls Church | Virginia | - | - |
Find similar trials in Birmingham, AL
Related Studies
- Evaluation of Patients With Liver DiseaseRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Blood Collection Biorepository for Liver Disease ResearchRecruiting · State University of New York at Buffalo · Buffalo, New York
- Project I Test: Implementing HIV Testing in Opioid Treatment ProgramsRecruiting · Columbia University · New York, New York
- ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load TestingNot Yet Recruiting · Johns Hopkins University · Baltimore, Maryland